Top Markets
#1 Akedo Akedo +73.50%
#2 MEET48 MEET48 +26.11%
#3 Bitway Bitway +21.76%
#4 VeThor VeThor +21.08%
#5 Power Protocol Power Protocol +17.38%
#6 Tutorial Tutorial +16.23%
#7 Astar Astar +14.86%
#8 龙虾 (Lobster) 龙虾 (Lobster) +12.72%
#9 Falcon Finance Falcon Finance +12.11%
#10 Arbitrum Arbitrum +12.09%
Coin of the day
Akedo Akedo
Настройки
Язык
Pусский
Валюта
USD
Тема
Acticor Biotech SAS Acticor Biotech SAS

Acticor Biotech SAS

ALACT
Ранг среди акций #37014
Acticor Biotech SAS is a clinical-stage biotechnology firm focused on creating... Acticor Biotech SAS is a clinical-stage biotechnology firm focused on creating therapies for the acute phase of thrombotic conditions. The company's lead compound, glenzocimab, is a humanized monoclonal antibody fragment specifically designed to target a particular platelet glycoprotein. Currently, Acticor Biotech is advancing two clinical programs, both in Phase II/III, for the registration of treatments for ischemic stroke. Additionally, it is conducting two other Phase II trials concerning significant cardiovascular emergencies, with anticipated clinical data expected from both its ischemic stroke research and studies related to COVID-19 respiratory distress syndrome. Established in 2013, the company operates from its headquarters in Paris, France.
Цена акции
$0.25974701
Последняя синхронизация: 2025-01-06
Рыночная капитализация
$2.04M
Изменение (1 день)
0.74%
Изменение (1 год)
0.00%
Страна
FR
Торговля Acticor Biotech SAS (ALACT)

Категория

Healthcare
Коэффициент P/B для Acticor Biotech SAS (ALACT)
Коэффициент P/B на September 2026 TTM: -0.57
Согласно последним финансовым отчетам и цене акций Acticor Biotech SAS, текущий коэффициент P/B (TTM) составляет -0.57. В конце 2022 он составлял -33.19.
История P/B для Acticor Biotech SAS с 2010 по 2026
Коэффициент P/B в конце каждого года
Год P/B Изменить
2026 (TTM) -0.57 -91.38%
2023 -6.59 -80.15%
2022 -33.19 -1,126.36%
2021 3.23 -87.62%
2020 26.12 538.96%
2019 4.09 17.85%
2018 3.47 -160.01%
2017 -5.78 -511.84%
2016 1.40 2.83%
2015 1.37 7.92%
2014 1.26 5.23%
2013 1.20 -8.34%
2012 1.31 -12.44%
2011 1.50 -91.22%
2010 17.05 0.00%
Коэффициент P/B для аналогичных компаний или конкурентов
Компания P/B Разница P/B Страна
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.5144 -1,247.10%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 7.3983 -1,402.75%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 3.9974 -803.89%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 8.5918 -1,612.91%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH